The role of nitric oxide and protein kinase C in lipopolysaccharide- mediated vascular hyporeactivity

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 9, Issue 1, 2006, Pages 119-123

  Karimi, Gholamreza ^a   Fatehi, Zahra ^b   Gholamnejad, Zahra ^b  

^a School of Pharmacy   (Iran)

^b Medical School   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CHELERYTHRINE; LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PROTEIN KINASE C;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; MALE; NONHUMAN; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT; RAT STRAIN; SEPTIC SHOCK; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE RELAXATION; THORACIC AORTA; VASCULAR RING; VASCULAR SMOOTH MUSCLE;

ACETYLCHOLINE; ANIMALS; AORTA; DRUG INTERACTIONS; ENDOTHELIAL CELLS; LIPOPOLYSACCHARIDES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENYLEPHRINE; PROTEIN KINASE C; RATS; VASOCONSTRICTION; VASODILATION;

EID: 33644844976     PISSN: 14821826     EISSN: 14821826     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Astiz ME, and Rackow EC. Septic shock. Lancet, 351: 1501-1505, 1998.
2. Glauster MP. Pathophysiologic basis of sepsis: considerations for future strategies of intervention. Crit Care Med, 28: S4-S8, 2000.
3. Groeneveld ABJ, Bronsveld W, Thijs LG. Hemodynamic determinants of mortality in human septic shock. Surgery, 99: 140-152, 1986.
4. Landry DW, and Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med, 345: 588-595, 2001.
5. Macarthur H, Westfall TC, Riley DP, Misko TP, Salvemini D. Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci, 97: 9753-9758, 2000.
6. Temple GE, Brown AN, Morinelli TA, Halushaka PV, Cook JA, Changes in vascular responsiveness to thromboxane mimetic in endotoxic tolerance. Shock, 16:389-392, 2001.
7. Lang CH, Bagby GJ, Ferguson JL, Spitzer JJ. Cardiac output and redistribution of organ blood flow in hypermetabolic sepsis. Am J Physiol, 246: R331-R337, 1984.
8. Mulder MF, Van Lambalgen AA, Van den Bos GC, Thijs LG. The fall of cardiac output in endotoxemic rats can not explain all changes in organ blood flow: a comparison between endotoxin and low venous return shock. Shock, 5:135-140, 1996.
9. Piepot HA, Boer C, Groenveled ABJ, Sipkema P. Lipopolysaccharide impairs endothelial nitric oxide synthesis in rat renal arteries. Kidney Int, 57:2502-2510, 2000.
10. Abraham E, Wunderink R, Silverman H, et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome. JAMA, 273: 934-941, 1995.
11. Marsh CB, Wewers MD. The pathogenesis of sepsis: factors that modulate the response to gram-negative bacterial infection. Clin Chest Med, 17: 183-197, 1996.
12. Parratt JR. Nitric oxide in sepsis and endotoxemia. J Antimicrob Chemother, 41: 31-39, 1998.
13. Stoclet JC, Martinez MC, Ohlamann P, Chasserot S, Schott C, Kleschyov AL, Schneider F. and Andriantsitohaina R. Induction of nitric oxide synthase and dual effects of nitric oxide and cyclooxygenase products in regulation of arterial contraction in human septic shock. Circulation, 100: 107-112, 1999.
14. Miyamoto A, Yamazaki Y, Takagi T, Ishiguro S, Nishio A. Enhancement of endotoxin-induced vascular hyporeactivity to phenylephrine in the thoracic aortas of Mg-deficient rats ex vivo. Life Sci, 73: 2713-2726, 2003.
15. Farmer MR, Roberts RE, Gardiner SM, Ralevic V. Effects of in vivo lipopolysaccharide infusion on vasoconstrictor function of rat isolated mesentery, kidney and aorta. J Pharmacol Exp Ther, 306: 538-545, 2003.
16. Farias NC, Borelli-Montigny GL, Fauaz G, Feres T, Borges AC. Different mechanism of LPS-induced vasodilation in resistance and conductance arteries from SHR and normotensive rats. Br J Pharmacol, 137: 213-220, 2002.
17. Piepot HA, Groeneveld ABJ, Van Lambalgen AA, Sipkema P. Endotoxin impairs endothelium-dependent vasodilation more in the coronary and renal arteries than in other arteries of the Rat. J Surg Res, 110: 413-418, 2003.
18. Lidington D, Ouellette Y, Tyml K. Endotoxin increases intracellular resistance in microvascular endothelial cells by a tyrosine kinase pathway. J Cell physiol, 185:117-125, 2000.
19. Han YL, Kang J, Li SH. Protein kinase C and protein tyrosine kinase mediate lipopolysaccharide-and cytokine-induced nitric oxide formation in vascular smooth muscle cells of rats. Sheng Li Xue Bao, 55:265-272, 2003.
20. McKenna TM, Clegg JM, Williams TJ. Protein kinase C is a mediator of lipopolysaccharide-induced vascular suppression in the rat aorta. Shock, 2: 84-89, 1994.
21. McKenna TM, Fan SX, Li S. Lipopolysaccharide-responsive protein kinase C isotypes in the adult rat aorta. Shock, 7:269-273, 1997.
22. Tremblay P, Houde M, Arbour N, Rochefort D, Masure S, Opdenakker G, Oth D. Differential effects of PKC inhibitors on gelatinase b and interleukin 6 production in the mouse macrophage. Cytokine, 7:130-136, 1995.
23. Li S, Huang FL, Feng Q, Liu J, Fan SX, McKenna TM. Overexpression of protein kinase C alpha enhances lipopolysaccharide-induced nitric oxide formation in vascular smooth muscle cells. J Cell Physiol, 176:402-411, 1998.
24. Pleiner J, Heere-Ress E, Langenberger H, Sieder AE, Bayerle-Eder M, Mittermayer F, Fuchsjager-Mayrl G, Bohm J, Jansen B, Wolzt M. Adrenoceptor hyporeactivity is responsible for Escherichia Coli endotoxin-induced acute vascular dysfunction in humans. Arterioscler Thromb Vasc: Biol, 22:95-100, 2002.
25. Wu MS, Yang CW, Bens M, Yu HM, Huang JY, Wu CH, Huang CC, Vandewalle A. Cyclosporin inhibits nitric oxide production in medullary ascending limb cultured cells. Nephrol Dial Transplant, 13:2814-20, 1998.
26. Yoshizumi M, Perrella MA, Burnett JC, Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res, 73:205-209, 1993.
27. Liu SF, Adcock IM, Old RW, Barnes PJ, Evans TW. Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment invivo in the rat. Crit Care Med, 24: 1219-1225, 1996.
28. Gunnett C A, Lund DD, Chu Y, Brooks II RM, Faraci FM, Heistad DD. NO-dependent vasorelaxation is impaired after gene transfer of inducible NO-synthase. Arterioscler Thromb Vasc Biol, 21:1281-1287, 2001.
29. Paul A, Doherty K, Plevin R. Differential regulation by protein kinase C isoforms of nitric oxide synthase induction in RAW 264.7 macrophages and rat aortic smooth muscle cells. Br J Pharmacol, 120: 940-946, 1997.